R&D | April 22, 2026
Leinco and CellCarta team up to power next-gen proteomics for cancer and targeted therapies
Together, the companies aim to deliver an integrated toolkit for biomarker discovery and clinical research
Together, the companies aim to deliver an integrated toolkit for biomarker discovery and clinical research
Solvents made from renewable feedstocks help reduce reliance on fossil-fuel-based materials
Policy symposium in Hyderabad focuses on life skills education and community?driven solutions
The company announced that its Phase III FENhance 1 and 2 studies both met their primary endpoints
The start of our Phase 3 trial for an H5 influenza vaccine marks a significant milestone
The approval, following a positive recommendation from the European Medicines Agency’s CHMP, makes the vaccine valid across all 27 EU member states
The unit is equipped with advanced monitoring systems and supported by a multidisciplinary team
These tests deliver results in 10–15 minutes at a cost of Rs 100–Rs 150, compared to conventional diagnostics which cost up to Rs 15,000
The Union Minister noted that heat stress contributes to a rise in both communicable diseases such as dengue and non-communicable conditions like cardiovascular disorder
The newly formed SAB will provide strategic direction across research, clinical development, and regulatory pathways
Subscribe To Our Newsletter & Stay Updated
